David A. Rosa
Known title: CEO and PresidentCIK: 0001540354
David A. Rosa's purchase track record
David A. Rosa has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/4/2025 | NMTC | $50K | +53.9% | +95.8% | +32.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NMTC | ▼ Sell | Tax Withholding | 2,458 | $2K | 3/31/2026 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 71,325 | $49K | 2/18/2026 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,458 | $2K | 12/31/2025 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,458 | $2K | 9/30/2025 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,458 | $2K | 6/30/2025 | View on chart |
| NMTC | ▲ Buy | Open Market | 100,000 | $50K | 4/4/2025 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,458 | $2K | 3/31/2025 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 71,325 | $83K | 2/18/2025 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $3K | 1/31/2025 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 4,697 | $4K | 12/31/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $1K | 11/30/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $2K | 10/31/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 4,697 | $5K | 9/30/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $2K | 8/31/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $2K | 7/31/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 4,697 | $4K | 6/30/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $2K | 5/31/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $3K | 4/30/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 19,673 | $23K | 4/21/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $3K | 3/31/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $3K | 2/29/2024 | View on chart |
| NMTC | ▲ Buy | Grant | 663,497 | $0 | 2/18/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $3K | 1/31/2024 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $4K | 12/31/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $3K | 11/30/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $4K | 11/2/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $2K | 10/31/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $2K | 9/30/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $2K | 8/31/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $2K | 7/31/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $3K | 6/30/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $3K | 5/31/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $3K | 4/30/2023 | View on chart |
| NMTC | ▲ Buy | Grant | 91,500 | $0 | 4/21/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 2,239 | $4K | 3/31/2023 | View on chart |
| NMTC | ▼ Sell | Tax Withholding | 53,750 | $79K | 2/3/2023 | View on chart |
| NMTC | ▲ Buy | Grant | 250,000 | $0 | 2/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
NeuroOne Reports Strong Q4 Sales, New $4.5M Order
NeuroOne Medical Technologies said its Q4 sales were about $3.8 million, up 38% from last year. The company also added a $4.5 million purchase order in September and expects FY26 sales of roughly $10.5 million, a 15.6% increase year‑over‑year. These results come as the share price sits near its 12‑touch support level of $1.63 and an RSI of 45.8.
NeuroOne Reports Strong Q4 Sales, New $4.5M Order. NeuroOne Medical Technologies said its Q4 sales were about $3.8 million, up 38% from last year. The company also added a $4.5 million purchase order in September and expects FY26 sales of roughly $10.5 million, a 15.6% increase year‑over‑year. These results come as the share price sits near its 12‑touch support level of $1.63 and an RSI of 45.8.